eGenesis Company
Xenotransplant
Investors
Investors Number:
27
Last Funding Date:
2021
Headquarters:
USA
Founded Date:
2014
Industry:
Risk Mitigation
Employee Number:
11-50
Last Funding Type:
Series C
Investor Type:
Late Stage Venture
Total Funding:
$265.00
Estimated Revenue:
$10M to $50M